| Prev Close | 2.94 |
| Open | 2.94 |
| Day Low/High | 2.89 / 3.05 |
| 52 Wk Low/High | 2.92 / 19.21 |
| Volume | 1.90M |
bluebird bio, Inc. (BLUE)
3.00
0.06
2.04
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 71.45B |
| Market Cap | 228.65M |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Trading Had an Odd Feel
There just wasn't a high level of commitment to the market.
On Hold for the ECB
Meanwhile, we have Netflix and IBM to entertain us.
This Market Is in Sad Shape
Potential for further downside is strong.
Uncharted Waters
This is an odd market right now.
Action Was Ugly, But Healthy
If the market gaps down in the morning, watch for the dip buyers.
Stick a Fork in 2014
We get a fresh start on Friday.
Too Much Big Picture
Everyone's too busy talking about what might happen in 2015.
Start Reflecting
2015 is going to play out differently than 2014.
Some Holiday Cheer
Biotechnology stocks see a very strong bounce.
Oil Lang Syne
The market's oil worries are long forgotton.
Absolutely Nothing Happened
There had been no catalysts.
Forget Calling a Bottom
Just be patient and protect capital.
The Complacency Is a Bit Disconcerting
But considering how the market rebounded today, it's understandable.
Damage to Indices Was Fairly Minimal
But stay disciplined, honor your stops and protect gains.
The Power of Momentum Won
Trends have a great tendency to persist.
Game Changer
Today's drubbing shakes things up.
It's Tough to Be a Bear
Weak action just entices bulls to put more cash to work.
Just Winding Down
Lazy, light-volume action kicks in ahead of the long weekend.
A Subtle Shift in Character
With the long weekend beckoning, the action will only get slower.
Solid Action All Around
Trading conditions are strong but not easy.
A Decent First Step
Does today's bounce means this little correction is ending?
Drugs IPOs Depend on Deals
Biotech IPOs that have relationships with established drug companies will do better than those going it alone.
